Kevin Imrie
- Pathology and Forensic Medicine top 10%
- Oncology
- Hematology top 10%
- Genetics
- Neurology
- Co-authors
- Rena BucksteinRobert FowlerH. Miles PrinceDavid AllanJoseph BrandweinFélix CoutureKathleen TompkinsHelena Jernström
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)Hematopoietic Stem Cell Transplantation (5 papers)Viral-associated cancers and disorders (4 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Kevin Imrie
16 papers receiving 320 citations
Peers
Comparison fields: 5 of 57
- Pathology and Forensic Medicine 153
- Oncology 140
- Hematology 86
- Genetics 62
- Neurology 60
Countries citing papers authored by Kevin Imrie
This map shows the geographic impact of Kevin Imrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Imrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Imrie more than expected).
Fields of papers citing papers by Kevin Imrie
This network shows the impact of papers produced by Kevin Imrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Imrie. The network helps show where Kevin Imrie may publish in the future.
Co-authorship network of co-authors of Kevin Imrie
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Imrie. A scholar is included among the top collaborators of Kevin Imrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Imrie. Kevin Imrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma. | 34 |
| 3 | 52 | |
| 4 | 12 | |
| 5 | 3 | |
| 6 | 26 | |
| 7 | 33 | |
| 8 | 21 | |
| 9 | Disseminated intravascular coagulation and PC-SPES: a case report and literature review. | 10 |
| 10 | 12 | |
| 11 | 6 | |
| 12 | 57 | |
| 13 | 7 | |
| 14 | Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. | 35 |
| 15 | Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation. | 15 |
| 16 | 2 |
About Kevin Imrie
Kevin Imrie is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 16 papers that have together received 332 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (153 citations), Hematology (86 citations) and Genetics (62 citations). Kevin Imrie has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Rena Buckstein, Robert Fowler, H. Miles Prince, David Allan, Joseph Brandwein, Félix Couture, Kathleen Tompkins, Helena Jernström, Bayardo Perez‐Ordoñez and Armand Keating. Their work appears in journals such as British Journal of Cancer, British Journal of Haematology and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.